Two main reasons:
A drop in gross margin from around 64% to 60% (discounting, higher input costs) Company goal is to get it back up.
Also remember YE24 has a full year of Bevilles revenue. So that is masking the fall in sales for MHJ core.
If and when the consumer economy improves, coupled with a tightly focused strategy by the company we should see a reversal of these two factors to a greater or lesser degree.
- Forums
- ASX - By Stock
- Ann: FY24 Trading Update
Two main reasons:A drop in gross margin from around 64% to 60%...
Featured News
Add MHJ (ASX) to my watchlist
(20min delay)
|
|||||
Last
51.5¢ |
Change
0.010(1.98%) |
Mkt cap ! $198.1M |
Open | High | Low | Value | Volume |
50.5¢ | 51.5¢ | 50.0¢ | $101.7K | 200.7K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 15000 | 50.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
51.5¢ | 12975 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 15000 | 0.500 |
1 | 20000 | 0.495 |
1 | 19000 | 0.485 |
2 | 14907 | 0.480 |
1 | 1569 | 0.475 |
Price($) | Vol. | No. |
---|---|---|
0.515 | 12975 | 1 |
0.520 | 49971 | 1 |
0.530 | 51661 | 2 |
0.540 | 1666 | 1 |
0.585 | 5880 | 1 |
Last trade - 16.10pm 10/10/2024 (20 minute delay) ? |
Featured News
MHJ (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, MD & CEO
James Graham
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online